NCT05195138 is a NA clinical trial of Mindfulness-Based Diabetes Education in Type 2 Diabetes, sponsored by University of Alabama at Birmingham.

Who is sponsoring NCT05195138?

NCT05195138 is sponsored by University of Alabama at Birmingham.

What drugs are being tested in NCT05195138?

Interventions in NCT05195138: Mindfulness-Based Diabetes Education, Standard Diabetes Self-Management Education (DSME).

What condition does NCT05195138 study?

NCT05195138 studies Type 2 Diabetes.

Is NCT05195138 still recruiting?

NCT05195138 is currently completed. Last updated 19 February 2026.

Last reviewed 2026-02-19 · How we verify

NCT05195138

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness-Based Diabetes Education for Adults With Elevated Diabetes Distress

Completed NA Last updated 19 February 2026

What this trial tests

NA trial testing Mindfulness-Based Diabetes Education in Type 2 Diabetes in 36 participants. Completed in 31 December 2025.

Timeline

31 May 2023

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	31 May 2023
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across United States

Drugs / interventions tested

Mindfulness-Based Diabetes Education
Standard Diabetes Self-Management Education (DSME)

Conditions studied

Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

University of Alabama at Birmingham

Who can join

Adults 19 to 70, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetes distress is common affecting over one-third of people with type 2 diabetes, negatively impacting self-management and outcomes, and disproportionately affecting low-income individuals. The proposed project will conduct a pilot randomized controlled trial comparing Mindfulness-Based Diabetes Education to standard Diabetes Self-Management Education in adults with type 2 diabetes and elevated diabetes distress who receive care within safety-net healthcare systems in order to assess feasibility and acceptability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Engagement in Hypertension and Diabetes Clinical Trials at Federally Qualified Health Centers: A Systematic Review.
Byiringiro S, Barsha RAA, Hinneh T, Uwiringiyimana E, et al · · 2025 · PMID 40232717 · DOI 10.1001/jamanetworkopen.2025.5258

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07254689 — The Food for Health Study · NA · recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05195138 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 19 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05195138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing